Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process.
consensus
modified Delphi process
ocular manifestation
atopic dermatitis
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
16 Sep 2020
16 Sep 2020
Historique:
pubmed:
15
9
2020
medline:
24
6
2021
entrez:
14
9
2020
Statut:
epublish
Résumé
There is a need for unified guidance on the management of ocular manifestations of atopic dermatitis and ocular manifestations associated with dupilumab in the Nordic region (Denmark, Finland, Norway and Sweden). This initiative gathered Nordic dermatologists and ophthalmologists to identify consensus in this area using a modified Delphi process. The initiative was led by a Nordic expert panel who developed a questionnaire that was circulated to a wider group. The results informed an agenda consisting of 24 statements to be voted on using a 5-point Likert scale at a meeting in Copenhagen on 24 April 2019. A facilitator moderated discussion and revised statements according to expert feedback for a second vote when required to reach consensus. Consensus was reached for 23 statements regarding the diagnosis, treatment and referral of these patients, which we hope will improve patient management in the Nordic region.
Identifiants
pubmed: 32926175
doi: 10.2340/00015555-3629
pmc: PMC9235002
doi:
Types de publication
Consensus Development Conference
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00264Références
Acta Derm Venereol. 2019 Apr 1;99(4):375-378
pubmed: 30653240
Immunol Allergy Clin North Am. 2010 Aug;30(3):323-36
pubmed: 20670816
J Allergy Clin Immunol. 2013 Nov;132(5):1132-8
pubmed: 24094544
J Clin Cell Immunol. 2011 Aug 10;2(3):
pubmed: 21994899
Allergy Asthma Proc. 2012 May-Jun;33(3):227-34
pubmed: 22584191
J Allergy Clin Immunol. 2012 Dec;130(6):1344-54
pubmed: 22951056
N Engl J Med. 2018 Jun 28;378(26):2475-2485
pubmed: 29782224
Allergy. 2020 Jan;75(1):116-126
pubmed: 31593343
Br J Dermatol. 2019 May;180(5):1248-1249
pubmed: 30597515
Br J Dermatol. 2019 Sep;181(3):459-473
pubmed: 30851191
Lancet. 2017 Jun 10;389(10086):2287-2303
pubmed: 28478972
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1224-1231
pubmed: 31056788
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1778-1780.e1
pubmed: 29432961
J Am Acad Dermatol. 2019 Jul;81(1):143-151
pubmed: 30825533
Curr Allergy Asthma Rep. 2006 Jul;6(4):292-8
pubmed: 16822381
N Engl J Med. 2017 Mar 16;376(11):1090-1
pubmed: 28296614
N Engl J Med. 2014 Jul 10;371(2):130-9
pubmed: 25006719
N Engl J Med. 2016 Dec 15;375(24):2335-2348
pubmed: 27690741
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e435-e436
pubmed: 31220376
J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1519-1531
pubmed: 28970084
Ann Nutr Metab. 2015;66 Suppl 1:8-16
pubmed: 25925336
Br J Dermatol. 2020 Feb;182(2):418-426
pubmed: 31145810
J Dermatol Sci. 2019 May;94(2):266-275
pubmed: 31109652
J Am Acad Dermatol. 2017 Aug;77(2):280-286.e1
pubmed: 28601391
Ophthalmol Ther. 2019 Sep;8(3):485-490
pubmed: 31230264
JAMA Dermatol. 2014 May;150(5):571-3
pubmed: 24500107
Br J Dermatol. 1976 Aug;95(2):207-8
pubmed: 952760